|
Real-time Estimate
Cboe BZX
14:09:50 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 5.180 USD | -0.19% |
|
-0.95% | -44.51% |
| 08-31 | Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80 | MT |
| 08-31 | Alvotech's Application for Proposed Entyvio Biosimilar Accepted for US FDA Review | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 48.01B | |||||
| 44.44B | - | - | - | - | - |
| 42.67B | |||||
| 39.96B | |||||
| 32.75B |
- Stock Market
- Stocks
- ALVO Stock
- ALVO Stock
- Charts Alvotech
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
